← Leaderboards
Cynthia Aranow
Feinstein Institute For Medical Research
$1,565,219
Attributed
$1,565,219
Total exposure
15
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $325.3K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,565,219 · 15
By mechanism
UM1$1,008,000 · 1
P01$459,392 · 2
M01$97,827 · 12
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Betty Diamond$68,537,262
- Patricio T Huerta$8,195,375
- Ping Wang$26,716,102
- Sangeeta S. Chavan$4,793,336
- Serge Sevy$1,998,778
Others in their field
Top investigators on “Systemic Lupus Erythematosus”
- Ignacio E. Sanz · University Of Rochester$57,737,718
- George C Tsokos · Beth Israel Deaconess Medical Center$37,219,358
- David Wofsy · University Of California, San Francisco$36,472,228
- Betty Diamond · Feinstein Institute For Medical Research$32,406,714
- John Barker Harley · Cincinnati Va Medical Center Research$30,355,689
- Patrick M Gaffney · University Of Minnesota Twin Cities$27,964,103
Research focus
Systemic Lupus ErythematosusSafetyClinical ResearchClinical TrialsResearch PersonnelSourceComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthAutoimmune DiseasesResourcesInflammationInstitutionFundingGrantIncidenceImmuneSiteRheumatoid ArthritisMedical ResearchClinically SignificantClinical EfficacyGeneticAutoimmunityAutoimmune Responses
Grant awards (24)
Clinical Core$134,057
P01 · FY2025 · AI · contact PI
Core B: Clinical Core$325,335
P01 · FY2024 · AI · contact PI
Novel Nontoxic Therapeutic Interventions for Autoimmune Inflammatory Disease$83,750
UM1 · FY2023 · AI · contact PI
Novel Nontoxic Therapeutic Interventions for Autoimmune Inflammatory Disease$83,750
UM1 · FY2022 · AI · contact PI
Novel Nontoxic Therapeutic Interventions for Autoimmune Inflammatory Disease$83,750
UM1 · FY2021 · AI · contact PI
Novel Nontoxic Therapeutic Interventions for Autoimmune Inflammatory Disease$83,750
UM1 · FY2020 · AI · contact PI
Novel Nontoxic Therapeutic Interventions for Autoimmune Inflammatory Disease$167,500
UM1 · FY2019 · AI · contact PI
Proposal for The Feinstein Center for Clinical Research in Autoimmune Disease$84,250
UM1 · FY2018 · AI · contact PI
Proposal for The Feinstein Center for Clinical Research in Autoimmune Disease$84,250
UM1 · FY2017 · AI · contact PI
Proposal for The Feinstein Center for Clinical Research in Autoimmune Disease$84,250
UM1 · FY2016 · AI · contact PI
Proposal for The Feinstein Center for Clinical Research in Autoimmune Disease$84,250
UM1 · FY2015 · AI · contact PI
Proposal for The Feinstein Center for Clinical Research in Autoimmune Disease$168,500
UM1 · FY2014 · AI · contact PI
CLINICAL TRIAL: A DOUBLE BLIND, PLACEBO CONTROLLED, PHASE II, RANDOMIZED STUDY O$13,141
M01 · FY2010 · RR · contact PI
THE RHEUMATOLOGY SPECIMEN BANK$11,869
M01 · FY2010 · RR · contact PI
EFFECT OF VITAMIN D3 ON THE IFNA SIGNATURE IN PATIENTS WITH LUPUS$10,174
M01 · FY2010 · RR · contact PI
THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) REGISTRY$6,782
M01 · FY2010 · RR · contact PI
AMERICAN COLLEGE OF RHEUMATOLOGY RE-CLASSIFICATION OF SLE CRITERIA (AROSE)$5,087
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: A MULTI-CENTER, OPEN-LABEL, CONTINUATION TRIAL OF LYMPHOSTAT-B A$423
M01 · FY2010 · RR · contact PI
THE RHEUMATOLOGY SPECIMEN BANK$26,148
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A DOUBLE BLIND, PLACEBO CONTROLLED, PHASE II, RANDOMIZED STUDY O$3,687
M01 · FY2009 · RR · contact PI
THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) REGISTRY$2,682
M01 · FY2009 · RR · contact PI
EFFECT OF VITAMIN D3 ON THE IFNA SIGNATURE IN PATIENTS WITH LUPUS$2,179
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A DOUBLE BLIND, PLACEBO CONTROLLED, PHASE II, RANDOMIZED STUDY O$10,130
M01 · FY2008 · RR · contact PI
THE RHEUMATOLOGY SPECIMEN BANK$5,525
M01 · FY2008 · RR · contact PI